Replies to post #1 on Neon Therapeutics (NTGN)

[jondoeuk]

This might be useful

In https://t.co/T8Ig1fRJrW, Keskin et al. designed a neoantigen vacc trial for pts with newly dx'd MGMT-unmethylated glioblastoma: 1) surgical resection, 2) radiotherapy (RT), 3) personalized neoantigen vacc (prepared using WES and RNA-seq, HLA-typing, and #NetMHCpan). /1

— Nils-Petter Rudqvist (@NP_Rudqvist) January 7, 2019